- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Implant facilitates breast radiation therapy
A new breast implant allows more patients to safely receive accelerated partial-breast irradiation than balloon brachytherapy or 3D conformal radiation, a study finds.
A new breast implant allows more patients to safely receive accelerated partial-breast irradiation than balloon brachytherapy or 3D conformal radiation, a study finds. The Strut Adjusted Volume Implant (SAVI) enables maximized dose to the target tissue and minimized dose to normal tissue.
Women with small breasts and/or inadequate skin and chest wall spacing face unacceptable toxicity with available accelerated partial-breast irradiation. SAVI is a multichannel, single-entry brachytherapy device designed to overcome that limitation.
After a median follow-up of two years, the researchers found overall dosimetry was outstanding. The median percentage of target volume receiving 90% of the prescription dose was 95.9%. (Int J Radiation Oncology Biol Phys doi:10.1016/j.ijrobp.2010.02.018).
“After almost two years, the patients showed the treatment was well-tolerated without significant side effects. To date, the control rate of cancer is also very promising,” said Dr. Catheryn Yashar, an associate professor of radiation oncology at the University of California, San Diego.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
